SilverArc Capital Management provides investment advice to private funds and separately managed accounts. SilverArc aims to maximize total return through capital appreciation, investing in equity securities, derivatives, and ETFs. SilverArc primarily focuses on the healthcare industry, investing in drug companies, medical device companies, and other life sciences companies. SilverArc may tailor its services based on each client's investment objectives.
Fee Structure
SilverArc Capital Management manages investments for private funds. The firm receives management fees from these funds, generally between 1.25% and 2.0% per year of the fund's net asset value. The general partner of the fund may also receive an incentive allocation, which is a percentage of the fund's net capital appreciation, typically between 15% and 22.5%. These rates may be negotiable.